-- ============================================================================
-- BATCH 7: Blood and Blood Products (Questions 277-326)
-- Topic: Blood components, transfusion medicine, compatibility
-- ============================================================================

INSERT INTO questions (topic_id, category_id, question_text, option_a, option_b, option_c, option_d, option_e, correct_option, explanation, difficulty, cognitive_level) VALUES

-- BLOOD COMPONENTS
('b0000007-0000-0000-0000-000000000007', 'a0000001-0000-0000-0000-000000000001',
'Whole blood can be separated into the following components EXCEPT:',
'Packed red blood cells',
'Platelets',
'Albumin',
'Fresh frozen plasma',
'Cryoprecipitate',
'C',
'Whole blood is separated into cellular components (RBCs, platelets) and plasma products (FFP, cryoprecipitate). Albumin is a plasma derivative made from pooled plasma by fractionation.',
'medium', 'knowledge'),

('b0000007-0000-0000-0000-000000000007', 'a0000001-0000-0000-0000-000000000001',
'The volume of one unit of packed red blood cells (PRBC) is approximately:',
'100 mL',
'250-350 mL',
'500 mL',
'50 mL',
'600 mL',
'B',
'One unit PRBC is approximately 250-350 mL (after removing plasma from ~450 mL whole blood donation). Hematocrit is 55-80%.',
'easy', 'knowledge'),

('b0000007-0000-0000-0000-000000000007', 'a0000001-0000-0000-0000-000000000001',
'One unit of PRBC is expected to raise hemoglobin by approximately:',
'0.5 g/dL',
'1 g/dL',
'2 g/dL',
'3 g/dL',
'0.1 g/dL',
'B',
'One unit PRBC raises Hb by approximately 1 g/dL (or Hct by 3%) in a 70kg adult. Response may be less with ongoing bleeding or hemolysis.',
'medium', 'knowledge'),

('b0000007-0000-0000-0000-000000000007', 'a0000001-0000-0000-0000-000000000001',
'PRBCs are stored at:',
'Room temperature',
'1-6°C',
'-18°C or colder',
'37°C',
'-80°C',
'B',
'PRBCs are stored at 1-6°C for up to 35-42 days (depending on preservative). Must be transfused within 4 hours of leaving refrigeration.',
'easy', 'knowledge'),

('b0000007-0000-0000-0000-000000000007', 'a0000001-0000-0000-0000-000000000001',
'The maximum storage time for PRBCs with CPDA-1 preservative is:',
'21 days',
'35 days',
'42 days',
'60 days',
'7 days',
'B',
'CPDA-1: 35 days storage. Additive solutions (AS-1, AS-3, AS-5) extend to 42 days. Citrate anticoagulates, phosphate buffers, dextrose provides energy, adenine maintains ATP.',
'medium', 'knowledge'),

('b0000007-0000-0000-0000-000000000007', 'a0000001-0000-0000-0000-000000000001',
'Fresh Frozen Plasma (FFP) contains:',
'Red blood cells and platelets',
'All coagulation factors and plasma proteins',
'Only clotting factors VIII and XIII',
'Concentrated fibrinogen only',
'Albumin only',
'B',
'FFP contains all coagulation factors, fibrinogen, albumin, and immunoglobulins. Indicated for multiple factor deficiencies, massive transfusion, warfarin reversal.',
'easy', 'knowledge'),

('b0000007-0000-0000-0000-000000000007', 'a0000001-0000-0000-0000-000000000001',
'FFP is stored at:',
'1-6°C',
'Room temperature',
'-18°C or colder',
'37°C',
'-4°C',
'C',
'FFP is frozen at -18°C or colder within 8 hours of collection, stored for up to 1 year. Once thawed, use within 24 hours (kept at 1-6°C).',
'medium', 'knowledge'),

('b0000007-0000-0000-0000-000000000007', 'a0000001-0000-0000-0000-000000000001',
'The standard dose of FFP is:',
'1 unit regardless of weight',
'10-15 mL/kg',
'5 mL/kg',
'30-40 mL/kg',
'50 mL/kg',
'B',
'FFP dose: 10-15 mL/kg (typically 2-4 units for adults). One unit is 200-250 mL. Goal is to raise factor levels by 20-30%.',
'medium', 'knowledge'),

('b0000007-0000-0000-0000-000000000007', 'a0000001-0000-0000-0000-000000000001',
'Platelets are stored at:',
'1-6°C with agitation',
'20-24°C with continuous agitation',
'-18°C frozen',
'37°C',
'Room temperature without agitation',
'B',
'Platelets are stored at 20-24°C (room temperature) with continuous gentle agitation for 5-7 days. Cold inactivates platelets.',
'medium', 'knowledge'),

('b0000007-0000-0000-0000-000000000007', 'a0000001-0000-0000-0000-000000000001',
'One unit of random donor platelets should raise platelet count by:',
'5,000-10,000/μL',
'30,000-60,000/μL',
'100,000/μL',
'150,000/μL',
'1,000/μL',
'A',
'One random donor platelet unit raises count by 5,000-10,000/μL. Apheresis unit (equivalent to 6 random units) raises by 30,000-60,000/μL in 70kg adult.',
'medium', 'knowledge'),

('b0000007-0000-0000-0000-000000000007', 'a0000001-0000-0000-0000-000000000001',
'Cryoprecipitate is rich in:',
'All coagulation factors',
'Fibrinogen, Factor VIII, vWF, Factor XIII, fibronectin',
'Platelets',
'Red blood cells',
'Albumin only',
'B',
'Cryoprecipitate (cryo) contains: Fibrinogen (150-250mg), Factor VIII, von Willebrand factor, Factor XIII, and fibronectin. Indicated for hypofibrinogenemia.',
'medium', 'knowledge'),

('b0000007-0000-0000-0000-000000000007', 'a0000001-0000-0000-0000-000000000001',
'The primary indication for cryoprecipitate is:',
'Thrombocytopenia',
'Hypofibrinogenemia or dysfibrinogenemia',
'Anemia',
'Warfarin reversal',
'Volume expansion',
'B',
'Cryo is indicated for: Fibrinogen <100-150 mg/dL, massive transfusion, DIC, Factor XIII deficiency, uremic bleeding. Not for hemophilia A (use factor concentrate).',
'medium', 'application'),

-- ABO AND RH BLOOD GROUPS
('b0000007-0000-0000-0000-000000000007', 'a0000001-0000-0000-0000-000000000001',
'A person with blood type A has:',
'A antigens on RBCs and anti-B antibodies in plasma',
'B antigens on RBCs and anti-A antibodies in plasma',
'Both A and B antigens on RBCs',
'Neither antigen on RBCs',
'A antigens on RBCs and anti-A antibodies',
'A',
'Type A: A antigens on RBCs, anti-B antibodies in plasma. Type B: B antigens, anti-A antibodies. Type AB: Both antigens, no antibodies. Type O: No antigens, both antibodies.',
'easy', 'knowledge'),

('b0000007-0000-0000-0000-000000000007', 'a0000001-0000-0000-0000-000000000001',
'The universal red blood cell donor is:',
'Type A',
'Type B',
'Type AB',
'Type O negative',
'Type O positive',
'D',
'Type O negative PRBCs can be given to any patient (no A, B, or Rh antigens to cause reaction). Used in emergencies when blood type is unknown.',
'easy', 'knowledge'),

('b0000007-0000-0000-0000-000000000007', 'a0000001-0000-0000-0000-000000000001',
'The universal plasma donor is:',
'Type O',
'Type A',
'Type B',
'Type AB',
'Any Rh negative',
'D',
'Type AB plasma has no anti-A or anti-B antibodies, so it can be given to any ABO type. Opposite of RBCs where O is universal donor.',
'medium', 'knowledge'),

('b0000007-0000-0000-0000-000000000007', 'a0000001-0000-0000-0000-000000000001',
'Rh (D) antigen is important because:',
'It is present on all blood cells',
'It can cause severe hemolytic reactions and hemolytic disease of newborn',
'It determines ABO compatibility',
'It is always present in donors',
'It only affects platelet transfusion',
'B',
'Rh(D) is highly immunogenic. Rh-negative patients can form anti-D after exposure (transfusion/pregnancy), causing hemolytic transfusion reactions or hemolytic disease of fetus/newborn.',
'medium', 'comprehension'),

('b0000007-0000-0000-0000-000000000007', 'a0000001-0000-0000-0000-000000000001',
'RhoGAM (Rh immunoglobulin) is given to:',
'Rh-positive mothers after delivery',
'Rh-negative mothers carrying Rh-positive fetus',
'All pregnant women',
'Rh-positive babies',
'Fathers only',
'B',
'RhoGAM prevents Rh-negative mothers from forming anti-D antibodies after exposure to Rh-positive fetal blood. Given at 28 weeks and within 72 hours of delivery.',
'medium', 'knowledge'),

-- TRANSFUSION REACTIONS
('b0000007-0000-0000-0000-000000000007', 'a0000001-0000-0000-0000-000000000001',
'The most common cause of fatal transfusion reactions is:',
'Bacterial contamination',
'ABO incompatibility due to clerical error',
'Allergic reaction',
'TRALI',
'Viral transmission',
'B',
'Clerical error causing ABO mismatch is the leading cause of fatal hemolytic transfusion reactions. Verification protocols at bedside are critical.',
'medium', 'knowledge'),

('b0000007-0000-0000-0000-000000000007', 'a0000001-0000-0000-0000-000000000001',
'Acute hemolytic transfusion reaction presents with all EXCEPT:',
'Fever and chills',
'Flank pain',
'Hypotension',
'Hemoglobinuria',
'Delayed onset 7-10 days after transfusion',
'E',
'Acute hemolytic reaction: Immediate onset with fever, chills, flank pain, hypotension, hemoglobinuria, DIC. Delayed hemolytic reaction occurs 3-14 days later.',
'medium', 'knowledge'),

('b0000007-0000-0000-0000-000000000007', 'a0000001-0000-0000-0000-000000000001',
'The first step in managing suspected acute hemolytic transfusion reaction is:',
'Give steroids',
'Stop the transfusion immediately',
'Increase IV fluids',
'Give epinephrine',
'Continue at slower rate',
'B',
'Immediately stop transfusion, maintain IV access, notify blood bank, send blood samples for investigation. Support with fluids, monitor urine output, treat DIC if present.',
'easy', 'application'),

('b0000007-0000-0000-0000-000000000007', 'a0000001-0000-0000-0000-000000000001',
'Febrile non-hemolytic transfusion reaction is caused by:',
'ABO incompatibility',
'Antibodies to donor leukocyte antigens or cytokines',
'Bacterial contamination',
'IgE-mediated allergy',
'Volume overload',
'B',
'Febrile reactions are due to recipient antibodies against donor WBC antigens (HLA) or cytokines accumulated during storage. Prevention: Leukoreduced products.',
'medium', 'knowledge'),

('b0000007-0000-0000-0000-000000000007', 'a0000001-0000-0000-0000-000000000001',
'Transfusion-related acute lung injury (TRALI) is characterized by:',
'Volume overload with cardiomegaly',
'Non-cardiogenic pulmonary edema within 6 hours',
'Hemoglobinuria',
'Delayed reaction after 1 week',
'Anaphylaxis',
'B',
'TRALI: Acute respiratory distress within 6 hours, bilateral infiltrates, no cardiomegaly (non-cardiogenic). Due to donor antibodies against recipient HLA/neutrophil antigens.',
'medium', 'knowledge'),

('b0000007-0000-0000-0000-000000000007', 'a0000001-0000-0000-0000-000000000001',
'TACO (transfusion-associated circulatory overload) differs from TRALI in that TACO shows:',
'Hypotension',
'Evidence of volume overload (elevated JVP, cardiomegaly)',
'Normal chest X-ray',
'Occurs days after transfusion',
'Fever as predominant symptom',
'B',
'TACO: Volume overload with elevated CVP/JVP, cardiomegaly, S3 gallop, responds to diuretics. TRALI: Non-cardiogenic, no volume overload signs.',
'medium', 'comprehension'),

('b0000007-0000-0000-0000-000000000007', 'a0000001-0000-0000-0000-000000000001',
'Allergic transfusion reactions are due to:',
'ABO incompatibility',
'Recipient IgE antibodies to donor plasma proteins',
'Bacterial contamination',
'Leukocyte antibodies',
'Rh incompatibility',
'B',
'Allergic reactions: IgE-mediated against donor plasma proteins. Range from urticaria (mild) to anaphylaxis (severe, especially in IgA deficiency).',
'medium', 'knowledge'),

('b0000007-0000-0000-0000-000000000007', 'a0000001-0000-0000-0000-000000000001',
'Patients with IgA deficiency are at risk for:',
'TRALI',
'Anaphylactic transfusion reaction',
'Delayed hemolytic reaction',
'Febrile reaction',
'TACO',
'B',
'IgA-deficient patients may have anti-IgA antibodies causing anaphylaxis when transfused with IgA-containing products. Use washed cellular products or IgA-deficient donors.',
'medium', 'knowledge'),

-- MASSIVE TRANSFUSION
('b0000007-0000-0000-0000-000000000007', 'a0000001-0000-0000-0000-000000000001',
'Massive transfusion is defined as:',
'More than 2 units of blood',
'Replacement of entire blood volume in 24 hours or 10 units in few hours',
'Any transfusion requiring warming',
'Transfusion requiring emergency release blood',
'More than 4 units of blood',
'B',
'Massive transfusion: ≥10 units PRBC in 24 hours, replacement of entire blood volume (70 mL/kg) in 24 hours, or >4 units in 1 hour with ongoing bleeding.',
'medium', 'knowledge'),

('b0000007-0000-0000-0000-000000000007', 'a0000001-0000-0000-0000-000000000001',
'Complications of massive transfusion include all EXCEPT:',
'Hypothermia',
'Hypocalcemia (citrate toxicity)',
'Hyperkalemia',
'Polycythemia',
'Coagulopathy',
'D',
'Massive transfusion complications: Hypothermia, hypocalcemia (citrate binds calcium), hyperkalemia (stored blood), dilutional coagulopathy, acidosis. Not polycythemia.',
'medium', 'comprehension'),

('b0000007-0000-0000-0000-000000000007', 'a0000001-0000-0000-0000-000000000001',
'Citrate toxicity from massive transfusion causes:',
'Hypernatremia',
'Hypocalcemia',
'Hyperglycemia',
'Metabolic alkalosis',
'Hypermagnesemia',
'B',
'Citrate anticoagulant binds ionized calcium causing hypocalcemia: perioral tingling, tetany, QT prolongation, hypotension. Treat with calcium gluconate or chloride.',
'medium', 'knowledge'),

('b0000007-0000-0000-0000-000000000007', 'a0000001-0000-0000-0000-000000000001',
'The recommended PRBC:FFP:Platelet ratio in massive transfusion protocol is:',
'4:1:1',
'1:1:1',
'6:2:1',
'10:2:1',
'1:2:1',
'B',
'Current evidence supports 1:1:1 ratio (balanced resuscitation) - mimics whole blood. Reduces mortality compared to higher PRBC ratios. Also give tranexamic acid.',
'medium', 'knowledge'),

('b0000007-0000-0000-0000-000000000007', 'a0000001-0000-0000-0000-000000000001',
'Blood warmers are essential during massive transfusion to prevent:',
'Hemolysis',
'Hypothermia and cardiac arrhythmias',
'Allergic reactions',
'Citrate toxicity',
'Bacterial contamination',
'B',
'Rapid transfusion of cold blood causes hypothermia, which impairs coagulation and causes cardiac arrhythmias (VFib risk). Use in-line blood warmer to 37°C.',
'medium', 'comprehension'),

-- BLOOD PRODUCT MODIFICATIONS
('b0000007-0000-0000-0000-000000000007', 'a0000001-0000-0000-0000-000000000001',
'Leukoreduced blood products are indicated for:',
'All emergency transfusions',
'Prevention of febrile reactions and CMV transmission',
'Treatment of sepsis',
'Volume expansion',
'Faster infusion rates',
'B',
'Leukoreduction removes WBCs, reducing: Febrile reactions, CMV transmission, HLA alloimmunization. Standard in many countries. Essential for transplant candidates.',
'medium', 'knowledge'),

('b0000007-0000-0000-0000-000000000007', 'a0000001-0000-0000-0000-000000000001',
'Irradiated blood products are indicated for:',
'All surgical patients',
'Prevention of transfusion-associated GVHD in immunocompromised patients',
'Emergency transfusion',
'Pediatric patients only',
'Prevention of TRALI',
'B',
'Irradiation inactivates donor T-lymphocytes, preventing TA-GVHD. Indicated for: BMT recipients, immunodeficiency, intrauterine transfusion, transfusion from relatives.',
'medium', 'knowledge'),

('b0000007-0000-0000-0000-000000000007', 'a0000001-0000-0000-0000-000000000001',
'Washed RBCs are indicated for:',
'Faster transfusion',
'Patients with severe allergic reactions or IgA deficiency',
'Increased shelf life',
'Cost reduction',
'Pediatric use only',
'B',
'Washing removes plasma proteins (reduces allergic reactions, removes IgA). Indicated for: Severe allergic reactions, IgA deficiency, paroxysmal nocturnal hemoglobinuria.',
'medium', 'knowledge'),

('b0000007-0000-0000-0000-000000000007', 'a0000001-0000-0000-0000-000000000001',
'CMV-negative blood products are required for:',
'All adult patients',
'CMV-seronegative transplant recipients and pregnant women',
'Emergency use only',
'Cost savings',
'Routine surgical patients',
'B',
'CMV-negative products for: Seronegative transplant recipients/donors, seronegative pregnant women, low birth weight infants. Leukoreduction is an acceptable alternative.',
'medium', 'knowledge'),

-- TRANSFUSION THRESHOLDS
('b0000007-0000-0000-0000-000000000007', 'a0000001-0000-0000-0000-000000000001',
'The restrictive transfusion threshold for hemoglobin in stable hospitalized patients is:',
'10 g/dL',
'9 g/dL',
'7-8 g/dL',
'6 g/dL',
'11 g/dL',
'C',
'Restrictive threshold: 7-8 g/dL for most stable patients (including critically ill). Higher thresholds (8-10 g/dL) for acute coronary syndrome, symptomatic anemia.',
'medium', 'knowledge'),

('b0000007-0000-0000-0000-000000000007', 'a0000001-0000-0000-0000-000000000001',
'Platelet transfusion is generally indicated when count is below:',
'150,000/μL',
'100,000/μL',
'50,000/μL for procedures or 10,000-20,000/μL prophylactically',
'200,000/μL',
'5,000/μL only',
'C',
'Prophylactic: <10,000/μL (or 20,000 with fever/bleeding). Procedures: <50,000/μL (or 100,000 for neurosurgery/eye surgery). Avoid in TTP/HIT unless life-threatening bleeding.',
'medium', 'knowledge'),

('b0000007-0000-0000-0000-000000000007', 'a0000001-0000-0000-0000-000000000001',
'FFP transfusion is indicated when:',
'Hemoglobin is low',
'INR >1.5-2.0 with bleeding or before invasive procedure',
'Platelet count is low',
'As volume expander',
'For any coagulopathy',
'B',
'FFP for: Active bleeding with coagulopathy (INR >1.5-2), before invasive procedure with INR >1.5-2, massive transfusion, TTP, warfarin reversal (with PCC).',
'medium', 'application'),

('b0000007-0000-0000-0000-000000000007', 'a0000001-0000-0000-0000-000000000001',
'Cryoprecipitate is indicated when fibrinogen level is below:',
'400 mg/dL',
'250 mg/dL',
'100-150 mg/dL',
'50 mg/dL only',
'200 mg/dL with no bleeding',
'C',
'Cryo indicated for fibrinogen <100-150 mg/dL (especially in massive transfusion, DIC, obstetric hemorrhage). Target fibrinogen >150 mg/dL.',
'medium', 'knowledge'),

-- AUTOLOGOUS AND DIRECTED DONATION
('b0000007-0000-0000-0000-000000000007', 'a0000001-0000-0000-0000-000000000001',
'Autologous blood donation refers to:',
'Donation from family members',
'Patient donating their own blood before elective surgery',
'Donation from the community',
'Emergency blood release',
'Directed donor blood',
'B',
'Autologous donation: Patient donates own blood 2-6 weeks before elective surgery. Eliminates infection/incompatibility risk. Requires Hb >11 g/dL, no bacteremia.',
'easy', 'knowledge'),

('b0000007-0000-0000-0000-000000000007', 'a0000001-0000-0000-0000-000000000001',
'Cell salvage (intraoperative blood salvage) is contraindicated in:',
'Cardiac surgery',
'Orthopedic surgery',
'Malignancy and contaminated surgical fields',
'Trauma surgery',
'Vascular surgery',
'C',
'Cell salvage contraindicated: Malignancy (tumor cell dissemination), bacterial contamination, amniotic fluid (relative). Wash cycle removes contaminants but not all.',
'medium', 'knowledge'),

('b0000007-0000-0000-0000-000000000007', 'a0000001-0000-0000-0000-000000000001',
'Acute normovolemic hemodilution involves:',
'Removing blood and replacing with crystalloid before surgery',
'Transfusing blood during surgery',
'Cell salvage',
'Apheresis',
'Plasmapheresis',
'A',
'ANH: Blood removed at start of surgery, replaced with crystalloid/colloid (maintaining normovolemia). Removed blood reinfused at end. Reduces allogeneic transfusion.',
'medium', 'knowledge');
